RecruitingNCT03190538

Nonalcoholic Steatohepatitis in Chinese Children

Nonalcoholic Steatohepatitis in Chinese Children: a Long Term Follow-up


Sponsor

Humanity and Health Research Centre

Enrollment

400 participants

Start Date

May 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Nonalcoholic steatohepatitis (NASH) is now recognised as an increasing clinical problem in children. Steatosis without significant liver cell injury or fibrosis is the most common form of nonalcoholic fatty liver disease (NAFLD) in both adults and children. Studies in the adult population have variably suggested that steatosis is a benign nonprogressive condition and NASH is recognised as a potentially serious condition with significantly risk of morbidity and mortality. A growing body of evidence suggests that children with NASH frequently show histopathological features that differ from those of adults. The prevalence of this pattern in a wide range of paediatric cases as well as other histopathological lesions and their relevance and prognostic significance in children with NAFLD remains to be determined. Thus the investigators would like to conduct a study of biopsies and clinical information to document the histological features of paediatric NAFLD, to explore the natural history of paediatric NAFLD, and to determine the frequency and prognostic value of these features.


Eligibility

Min Age: 1 YearMax Age: 18 Years

Inclusion Criteria2

  • age 1-18 with biopsy-proven NAFLD
  • Alcohol consumption less than 20g/day and 10g/day for boys and girls respectively

Exclusion Criteria5

  • with viral hepatitis, e.g. HBV, HCV
  • with a1-anti-trypsin disease
  • with autoimmune hepatitis
  • with Wilson disease
  • with liver impaired by drugs

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

There will be no specific intervention to these paediatric NASH patient


Locations(1)

Children's Liver Disease Center, 302 Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03190538


Related Trials